Clarapath
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$99.7k | Grant | ||
N/A | Seed | ||
N/A | $4.2m | Early VC | |
N/A | $16.0m | Series B | |
$16.0m | Series B | ||
$11.3m | Series B | ||
* | $36.0m | Series B | |
Total Funding | AUD129m |
Recent News about Clarapath
EditClarapath operates in the healthcare sector, specifically within the pathology and laboratory services market. The company has developed the SectionStar, an automated and robotic device that streamlines nine labor-intensive microtomy steps into a single piece of equipment. This innovation results in higher quality slides, faster turnaround times, and reduced costs. Clarapath also runs a CLIA certified lab offering a variety of Contract Research Organization (CRO) services, including Routine Histology, Whole Slide Imaging, Quantitative Image Analysis, and Data Hosting Management. The primary clients served by Clarapath include hospitals, research institutions, and pharmaceutical companies. The business model revolves around selling the SectionStar device and providing lab services on a contract basis. Revenue is generated through the sale of the SectionStar device and fees for lab services.
Keywords: Automated pathology, robotic microtomy, CLIA certified lab, Routine Histology, Whole Slide Imaging, Quantitative Image Analysis, Data Hosting, healthcare innovation, laboratory efficiency, cost reduction.